Beam stock forecast.

Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.

Beam stock forecast. Things To Know About Beam stock forecast.

Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts.Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.According to analyst projections, BEAM’s forecast low is $19.00 with $95.00 as the target high. To hit the forecast high, the stock’s price needs a -219.33% plunge from its current level, while the stock would need to tank 36.13% for it to hit the projected low. Beam Therapeutics Inc (BEAM) estimates and forecasts

The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...Motley Fool Issues Rare Triple-Buy Alert. This Stock Could Be Like Buying Amazon for $3.19. Find real-time Symbol not found stock quotes, company profile, news and forecasts from CNN Business.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Taiwan Semiconductor Manufacturing Co Ltd have a median target of 115.00, with a high estimate of 130.00 and a low ...

The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak . Nov 23, 2023 · Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years. Find the latest Roku, Inc. (ROKU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Their consensus HOOD stock forecast was that it could hit $13.36, which would represent a potential upside of 39.28% over the $9.59 closing price on 20 November, 2022. The highest Robinhood stock forecast 2023 prediction came in at $28 and the lowest warned it could slip to just $7. HOOD stock was also a ‘hold’, according to the …Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …

Stock Price Forecast The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 46.50, with a high estimate of 95.00 and a low estimate of 19.00. The median estimate represents a +57.09% increase from the last price of 29.60.

A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time AI - C3.ai Inc stock quotes, company profile, news and forecasts from CNN Business.Infibeam Avenues share price was Rs 20.15 as on 01 Dec, 2023, 03:59 PM IST. Infibeam Avenues share price was up by 0.74% based on previous share price of Rs 20.4. Infibeam Avenues share price trend: Last 1 Month: Infibeam Avenues share price moved up by 6.33%.Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business.GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.Strong Buy Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile 3m (25.40%) 12m (-35.51%) Bollinger Bands …See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... “This call aims to develop an USPL that is ruggedized enough to begin testing in relevant Army environments,” it continued. The Army also began testing a prototype laser weapon for close-range air defense in May, the Defense Post reported.The high-energy laser will be able to locate, lock on, track and destroy aerial threats in just seconds.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Taiwan Semiconductor Manufacturing Co Ltd have a median target of 115.00, with a high estimate of 130.00 and a low ...BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32. Beam Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 28, 2023 4:20 p.m. EST Delayed quote $ 29.77 0.00 0.00% After Hours Volume: 14.9K Advanced Charting Volume:... Find real-time BEEM - Beam Global stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.28: Annual revenue (last year) $22.0M: Annual profit (last ...View the latest Verizon Communications Inc. (VZ) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Tomorrow's movement Prediction of Infibeam Incorp. INFIBEAM appears to be in uptrend. And this trend seems to be continuing further. Price is above an important level of 20.84 on charts, and as long as price remains …

These 4 analysts have an average price target of $48.5 versus the current price of Beam Therapeutics at $23.8, implying upside. Below is a summary of how these 4 analysts rated Beam Therapeutics ...See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .Electronic Technology. Industry. Aerospace & Defense. No executives to display. Corporate headquarters. --, --. Find real-time ACHR - Archer Aviation Inc stock quotes, company profile, news and ...Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...Dec 1, 2023 · Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis.

11 brokers have issued 12 month price objectives for Beam Therapeutics' stock. Their BEAM share price targets range from $20.00 to $105.00. On average, they …

BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.

The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion provision in the ‘Build Back Better’ bill to political pressure on automakers to commit to ...Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.Beam Global's stock was trading at $9.97 on January 1st, 2023. Since then, BEEMW stock has decreased by 80.1% and is now trading at $1.9850. View the best growth stocks for 2023 here.(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts.BEST Inc. (NYSE:BEST) announced its earnings results on Monday, August, 16th. The company reported ($22.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($14.60) by $7.60. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.26 billion.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an …Chronic organ damage is the leading cause of death in adults with SCD. Beam is advancing multiple base editing programs for sickle cell disease, led by Beam-101, an ex vivo cell therapy in which cells are collected from a patient, edited, and then infused back into the patient. To create space for the edited cells to take hold in the bone ...Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive …Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ...Instagram:https://instagram. best minecraft server hostmicrosoft stock price predictionpipeline stockwhen does arm ipo go public Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more. chipoltle stockoption surge View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Aug 29, 2023 · BEAM stock, belonging to Beam Therapeutics Inc, has shown promising performance on August 29, 2023, according to data from CNN Money. The 15 analysts offering 12-month price forecasts for BEAM stock have a median target of $56.00, with a high estimate of $105.00 and a low estimate of $32.00. new crypto on coinbase NEW YORK, February 15, 2023--Beam Suntory, a world leader in premium spirits, today announced 2022 full year results, with net sales up 10.5% year on year, representing 24% growth versus the pre ...Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.